A detailed history of Larson Financial Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Larson Financial Group LLC holds 16,132 shares of ABBV stock, worth $3.23 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
16,132
Previous 5,340 202.1%
Holding current value
$3.23 Million
Previous $972,000 184.57%
% of portfolio
0.19%
Previous 0.08%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$154.79 - $180.76 $1.67 Million - $1.95 Million
10,792 Added 202.1%
16,132 $2.77 Million
Q1 2024

May 03, 2024

BUY
$159.82 - $182.1 $400,349 - $456,160
2,505 Added 88.36%
5,340 $972,000
Q4 2023

Feb 01, 2024

BUY
$137.6 - $154.97 $41,968 - $47,265
305 Added 12.06%
2,835 $439,000
Q3 2023

Nov 03, 2023

BUY
$133.59 - $154.65 $71,604 - $82,892
536 Added 26.88%
2,530 $377,000
Q2 2023

Aug 03, 2023

SELL
$132.51 - $164.9 $2,517 - $3,133
-19 Reduced 0.94%
1,994 $268,000
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $35,140 - $40,469
243 Added 13.73%
2,013 $320,000
Q4 2022

Feb 03, 2023

BUY
$138.31 - $165.87 $2,212 - $2,653
16 Added 0.91%
1,770 $286,000
Q3 2022

Nov 03, 2022

SELL
$134.21 - $153.93 $407,595 - $467,485
-3,037 Reduced 63.39%
1,754 $235,000
Q2 2022

Aug 04, 2022

SELL
$137.62 - $174.96 $65,782 - $83,630
-478 Reduced 9.07%
4,791 $734,000
Q1 2022

May 05, 2022

SELL
$131.98 - $163.75 $21,248 - $26,363
-161 Reduced 2.97%
5,269 $854,000
Q4 2021

Feb 03, 2022

SELL
$107.43 - $135.93 $34,162 - $43,225
-318 Reduced 5.53%
5,430 $735,000
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $541,044 - $614,166
5,085 Added 766.97%
5,748 $620,000
Q2 2021

Aug 10, 2021

BUY
$105.21 - $117.21 $736 - $820
7 Added 1.07%
663 $75,000
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $2,250 - $2,477
22 Added 3.47%
656 $71,000
Q4 2020

Jan 14, 2021

BUY
$80.49 - $108.67 $563 - $760
7 Added 1.12%
634 $68,000
Q3 2020

Oct 08, 2020

SELL
$85.91 - $100.83 $945 - $1,109
-11 Reduced 1.72%
627 $55,000
Q2 2020

Jul 10, 2020

BUY
$73.37 - $98.18 $16,875 - $22,581
230 Added 56.37%
638 $63,000
Q1 2020

Apr 09, 2020

SELL
$64.5 - $97.79 $709 - $1,075
-11 Reduced 2.63%
408 $31,000
Q4 2019

Jan 10, 2020

SELL
$72.13 - $90.25 $20,412 - $25,540
-283 Reduced 40.31%
419 $37,000
Q3 2019

Oct 11, 2019

BUY
$62.98 - $75.72 $14,422 - $17,339
229 Added 48.41%
702 $53,000
Q2 2019

Jul 16, 2019

BUY
$65.7 - $83.98 $4,664 - $5,962
71 Added 17.66%
473 $34,000
Q1 2019

Apr 05, 2019

BUY
$77.14 - $90.79 $385 - $453
5 Added 1.26%
402 $32,000
Q4 2018

Feb 07, 2019

BUY
$77.85 - $96.01 $30,906 - $38,115
397 New
397 $37,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Larson Financial Group LLC Portfolio

Follow Larson Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Larson Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Larson Financial Group LLC with notifications on news.